Main > HEPATOLOGY > USA. M. ALGS>Treat.>ASBTI>Oral Soln



USA. M. ALGS>Treat.>ASBTI>Oral Soln's subsections
(*) CA Approval Date: 2023. 07.25
(*) CN Approval Date: 2023. 06.01
(*) EU CE Mark Date: 2022. 12.13
(*) USA Approval Date: 2021. 09.29
ASBTI: Apical Sodium dependent>
Company
Company Licensee CN
Generic Name:
RTM
RTM Web-Site
USA Patent Numbers

USA. M. ALGS>Treat.>ASBTI>Oral Soln's products
This section has no products